Acquired Hemophilia A.

Hematol Oncol Clin North Am

McMaster University, Hamilton, Canada; Hamilton Health Sciences, Hamilton, Canada; Hamilton Regional Laboratory Medicine Program, Hamilton, Canada. Electronic address:

Published: December 2021

Acquired hemophilia A is a potentially severe bleeding disorder caused by antibodies against the patient's own factor VIII. Acquired hemophilia A is rare. It is most commonly diagnosed in older individuals; about one-half of cases of acquired hemophilia are associated with underlying conditions, including autoimmune disease, cancer, and pregnancy. The diagnosis of acquired hemophilia A can be suspect with an isolated activated partial thromboplastin time elevation, and confirmed with demonstration of reduced factor VIII activity and the presence of a specific factor VIII inhibitor. Treatment of acquired hemophilia A involves control of bleeding, and eradication of the inhibitor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2021.07.007DOI Listing

Publication Analysis

Top Keywords

acquired hemophilia
24
factor viii
12
acquired
6
hemophilia
5
hemophilia acquired
4
hemophilia severe
4
severe bleeding
4
bleeding disorder
4
disorder caused
4
caused antibodies
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!